Trial studying safety and effects for Hemophilia A
Official title Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
ClinicalTrials.gov ID: NCT05568719
What this study is testing
- What it's testing
- To learn about the long-term safety and effectiveness of specific gene therapies for Hemophilia A or B.
- Who it's for
- People with Hemophilia A or B who have already taken part in a previous Pfizer clinical trial.
- What's involved
- Participants will receive standard medical care and have regular check-ups to monitor their health.
- Time commitment
- The study involves long-term follow-up visits based on standard medical care.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- -Only participants who received investigational giroctocogene fitelparvovec or fidanacogene eleparvovec and were enrolled in a Pfizer-sponsored study...
You likely can't join if
- -None
The study team makes the final eligibility decision.
Where it is enrolling
- Rancho Cordova, California, United States
- Sacramento, California, United States
- San Francisco, California, United States
- Tampa, Florida, United States
- Indianapolis, Indiana, United States
- New York, New York, United States
- Philadelphia, Pennsylvania, United States
- Seattle, Washington, United States
- Camperdown, New South Wales, Australia
- Melbourne, Victoria, Australia
- Toronto, Ontario, Canada
- Bron, Rhône, France
- Paris, France
- Bonn, North Rhine-Westphalia, Germany
- Athens, Greece
- Nagoya, Aichi-ken, Japan
- Sapporo, Hokkaido, Japan
- Iruma-gun, Saitama, Japan
- Seoul, South Korea
- Valladolid, Spain
+ 9 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rancho Cordova, California, United States; Sacramento, California, United States; San Francisco, California, United States; Tampa, Florida, United States; Indianapolis, Indiana, United States; New York, New York, United States and 23 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.